Free Trial

Castle Biosciences (CSTL) SEC Filings & 10K Form

Castle Biosciences logo
$14.65 -0.50 (-3.30%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$15.58 +0.93 (+6.34%)
As of 08/1/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Castle Biosciences SEC Filings

DateFilerForm TypeView
07/01/2025
3:05 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
5:11 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2025
4:01 PM
Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:39 PM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
7:19 PM
BlackRock, Inc. (Filed by)
Castle Biosciences (Subject)
Form SCHEDULE 13G/A
04/14/2025
2:34 PM
Castle Biosciences (Subject)
Portolan Capital Management, LLC (Filed by)
Form SCHEDULE 13G
04/10/2025
3:07 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
10:43 AM
Castle Biosciences (Filer)
Form DEF 14A
04/09/2025
10:45 AM
Castle Biosciences (Filer)
Form DEFA14A
04/09/2025
10:47 AM
Castle Biosciences (Filer)
Form ARS
04/08/2025
3:56 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2025
6:06 PM
Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
Form 4/A
03/12/2025
3:30 PM
Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
Form 4/A
03/06/2025
3:10 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:28 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:10 PM
Castle Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM
Castle Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2025
3:23 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:25 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
8:33 PM
Castle Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/15/2025
3:57 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
5:58 AM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
5:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:17 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:18 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:39 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:21 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:00 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:55 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:09 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:28 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:14 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
5:21 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
5:44 PM
Castle Biosciences (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
11/06/2024
3:21 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:32 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:33 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
4:34 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:49 PM
Castle Biosciences (Subject)
Juvenal Tobin W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
3:34 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:22 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
A new rule goes live in July — and the banks are quietly crushing it (Ad)

A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.

To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how
10/09/2024
3:30 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:48 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:33 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:23 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:33 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:15 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
4:18 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:06 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:07 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:11 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:17 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
5:13 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
5:14 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
5:15 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
5:16 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
5:17 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:37 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2024
2:13 PM
Castle Biosciences (Subject)
Stokes Frank (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CSTL) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners